A 4-week, open-label, multicenter, urodynamic pilot study to explore the efficacy, tolerability and safety of darifenacin (7.5 mg with up-titration to 15 mg) in patients with multiple sclerosis and neurogenic detrusor overactivity A 4-week, open-label, multicenter, urodynamic pilot study to explore the efficacy, tolerability and ...
A 4-week, open-label, multicenter, urodynamic pilot study to explore the efficacy, tolerability and safety of darifenacin (7.5 mg with up-titration to 15 mg) in patients with multiple sclerosis and neurogenic detrusor overactivity A 4-week, open-label, multicenter, urodynamic pilot study to explore the efficacy, tolerability and ...
Neurogenic overactive bladder disaese in patients with multiple sclerosis MedDRA version: 8.1;Level: LLT;Classification code 10059617;Term: Overactive bladder Neurogenic overactive bladder disaese in patients with multiple sclerosis MedDRA version: 8.1;Level: ...
Trade Name: EMSELEX 7,5 mg Retardtabletten Product Name: Darifenacin Product Code: BAY 79-4998 INN or Proposed INN: Darifenacin Trade Name: EMSELEX 15 mg Retardtabletten Product Name: Darifenacin Product Code: BAY 79-4998 INN or Proposed INN: Darifenacin Trade Name: EMSELEX7,5 mg Retardtabletten Product Name: Darifenacin Product Code: BAY 79-4998 INN or Pr ...